Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)

NSE:AAREYDRUGS Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 18, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	2,040	942	1,253	601	1,051	543
Market Cap Growth	55.97%	-24.82%	108.61%	-42.83%	93.71%	74.44%
Enterprise Value	2,527	1,314	1,553	842	1,276	716
Last Close Price	71.39	33.51	43.65	24.00	41.45	-
PE Ratio	59.38	23.42	26.76	15.93	16.03	8.33
PS Ratio	0.52	0.20	0.31	0.14	0.21	0.15
PB Ratio	1.37	0.68	0.94	0.51	0.93	0.55
P/TBV Ratio	1.37	0.68	0.94	0.51	0.93	0.55
P/FCF Ratio	-	18.49	-	-	-	20.89
P/OCF Ratio	-	9.15	-	-	210.69	9.91
EV/Sales Ratio	0.65	0.28	0.39	0.20	0.26	0.20
EV/EBITDA Ratio	100.98	18.61	13.54	10.18	10.62	7.83
EV/EBIT Ratio	-	25.69	15.89	12.58	12.73	8.70
EV/FCF Ratio	-	25.78	-	-	-	27.58
Debt / Equity Ratio	0.38	0.31	0.24	0.32	0.13	0.18
Debt / EBITDA Ratio	22.76	6.17	2.73	4.56	1.18	1.97
Debt / FCF Ratio	-	8.55	-	-	-	6.94
Net Debt / Equity Ratio	0.33	0.29	0.21	0.31	0.12	0.18
Net Debt / EBITDA Ratio	19.49	5.71	2.48	4.43	1.16	1.90
Net Debt / FCF Ratio	-	7.91	-7.66	-15.74	-8.21	6.69
Asset Turnover	-	1.60	1.35	1.56	2.06	1.65
Inventory Turnover	-	6.43	5.57	6.66	9.16	5.49
Quick Ratio	-	0.92	1.13	1.14	1.08	1.24
Current Ratio	-	1.78	1.70	1.61	1.73	1.67
Return on Equity (ROE)	-	2.97%	3.74%	3.26%	6.17%	6.81%
Return on Assets (ROA)	-	1.08%	2.05%	1.56%	2.62%	2.41%
Return on Invested Capital (ROIC)	0.11%	1.98%	5.43%	2.98%	5.37%	5.72%
Return on Capital Employed (ROCE)	-	3.60%	7.10%	5.40%	8.50%	8.10%
Earnings Yield	1.68%	4.27%	3.74%	6.28%	6.24%	12.01%
FCF Yield	-	5.41%	-2.96%	-3.87%	-1.62%	4.79%
Buyback Yield / Dilution	-4.15%	-11.18%	0.26%	-5.84%	-2.95%	-
Total Shareholder Return	-4.15%	-11.18%	0.26%	-5.84%	-2.95%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.